Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Robert-Bosch-Krankenhaus GmbH is engaged in the Biotechnology & Pharmaceuticals technology area. Currently, the portfolio includes 1 pending office action. This action is being examined by 1 distinct examiner, indicating a focused approach to its current patent filings. This structure allows for a direct and consistent prosecution path.
FRUMKIN, JESSE P serves as the busiest examiner for the portfolio, managing 1 busiest examiner pending office action. Given that there is 1 pending office action total, FRUMKIN, JESSE P is responsible for the entirety of the current examination process. A practitioner can concentrate on the specific feedback and requirements provided by this examiner to advance the application.
The prosecution is confined to 1 distinct art unit. This concentration implies that the technical innovations are specialized and subject to the specific standards of that unit. By focusing on the 1 distinct art unit and the 1 busiest examiner pending action, the practitioner can develop a targeted strategy to resolve the 1 pending office action effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRUMKIN, JESSE P | 1 | 69.9% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251058 | COMPUTER-IMPLEMENTED METHOD AND DEVICE FOR CARRYING OUT A MEDICAL LABORATORY VALUE ANALYSIS | FRUMKIN, JESSE P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251058 | COMPUTER-IMPLEMENTED METHOD AND DEVICE FOR CARRYING OUT A MEDICAL LABORATORY VALUE ANALYSIS | FRUMKIN, JESSE P | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18251058 | COMPUTER-IMPLEMENTED METHOD AND DEVICE FOR CARRYING OUT A MEDICAL LABORATORY VALUE ANALYSIS | FRUMKIN, JESSE P | 1685 | §101§102§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRobert-Bosch-Krankenhaus GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jesse P Frumkin has the most, with 1 of Robert-Bosch-Krankenhaus GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
